Characterization of the anti-inflammatory Lactobacillus reuteri BM36301 and its probiotic benefits on aged mice

BMC Microbiology

Volumn 16, Issue 1, 2016, Pages

  Lee, Joon ^a   Yang, Woo ^a   Hostetler, Andrew ^a   Schultz, Nathan ^a   Suckow, Mark A ^b,c   Stewart, Kay L ^b   Kim, Daniel D ^a   Kim, Hyung Soo ^a  

^a Research and Development   (United States)

^b UNIVERSITY OF NOTRE DAME   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Aging; Anti inflammatory; C57BL 6 mice; Hair growth; L. reuteri; Lactic acid bacteria; Probiotics; Skin health; Testosterone; TNF

Indexed keywords

ANTIINFLAMMATORY AGENT; BM 36301; BM 36304; INSULIN; INTERLEUKIN 10; PROBIOTIC AGENT; TESTOSTERONE; TOLL LIKE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CULTURE MEDIUM; TUMOR NECROSIS FACTOR;

AGED; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG EFFICACY; DRUG SCREENING; FEMALE; HAIR GROWTH; HUMAN; HUMAN CELL; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; INHIBITION ZONE; INSULIN BLOOD LEVEL; LACTOBACILLUS REUTERI; LIPID STORAGE; MALE; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; OVARY FOLLICLE DEVELOPMENT; PROTEIN BLOOD LEVEL; PROTEIN INDUCTION; SEX DIFFERENCE; SURVIVAL RATE; TESTOSTERONE BLOOD LEVEL; WEIGHT GAIN; AGING; ANIMAL; C57BL MOUSE; CELL LINE; CULTURE MEDIUM; DRUG EFFECTS; IMMUNOLOGY; INTESTINE FLORA; ISOLATION AND PURIFICATION; METABOLISM; PHARMACOLOGY; UPREGULATION;

AGING; ANIMALS; ANTI-INFLAMMATORY AGENTS; CELL LINE; CULTURE MEDIA; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; LACTOBACILLUS REUTERI; MALE; MICE; MICE, INBRED C57BL; PROBIOTICS; SEX FACTORS; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 84966351121     PISSN: None     EISSN: 14712180     Source Type: Journal    
DOI: 10.1186/s12866-016-0686-7     Document Type: Article

References (49)

1. Dorrestein PC, Mazmanian SK, Knight R. Finding the missing links among metabolites, microbes, and the host. Immunity. 2014;40(6):824-32.
2. Versalovic J. The human microbiome and probiotics: implications for pediatrics. Ann Nutri Metab. 2013;63 Suppl 2:42-52.
3. Gilbert JA, Krajmalnik-Brown R, Porazinska DL, Weiss SJ, Knight R. Toward effective probiotics for autism and other neurodevelopmental disorders. Cell. 2013;155(7):1446-8.
4. Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem. 2013;59(4):617-28.
5. Mayer EA, Knight R, Mazmanian SK, Cryan JF, Tillisch K. Gut Microbes and the Brain: Paradigm Shift in Neuroscience. J Neurosci. 2014;34(46):15490-6.
6. Turroni F, Ventura M, Butto LF, Duranti S, O'Toole PW, Motherway MO, van Sinderen D. Molecular dialogue between the human gut microbiota and the host: a Lactobacillus and Bifidobacterium perspective. Cell Mol Life Sci. 2014;71(2):183-203.
7. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev. 2010;90(3):859-904.
8. Madsen KL. The use of probiotics in gastrointestinal disease. Can J Gastroenterol. 2001;15(12):817-22.
9. Reid G, Jass J, Sebulsky MT, McCormick JK. Potential Uses of Probiotics in Clinical Practice. Clin Microbiol Rev. 2003;16(4):658-72.
10. Scaldaferri F, Gerardi V, Lopetuso LR, Del Zompo F, Mangiola F, Boškoski I, Bruno G, Petito V, Laterza L, Cammarota G. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int. 2013;2013:435268-76.
11. Perdigon G, Fuller R, Raya R. Lactic acid bacteria and their effect on the immune system. Curr Issues Intest Microbiol. 2001;2(1):27-42.
12. Hörmannsperger G, Haller D. Molecular crosstalk of probiotic bacteria with the intestinal immune system: clinical relevance in the context of inflammatory bowel disease. Int J Med Microbiol. 2010;300(1):63-73.
13. Wells J. Immunomodulatory mechanisms of lactobacilli. Microb Cell Fact. 2011;10(1):1-15.
14. Jacobsen CN, Rosenfeldt Nielsen V, Hayford AE, Moller PL, Michaelsen KF, Paerregaard A, Sandstrom B, Tvede M, Jakobsen M. Screening of probiotic activities of forty-seven strains of Lactobacillus spp. by in vitro techniques and evaluation of the colonization ability of five selected strains in humans. Appl Environ Microbiol. 1999;65(11):4949-56.
15. Foligne B, Daniel C, Pot B. Probiotics from research to market: the possibilities, risks and challenges. Curr Opin Microbiol. 2013;16(3):284-92.
16. Bernet M-F, Brassart D, Neeser J, Servin A. Adhesion of human bifidobacterial strains to cultured human intestinal epithelial cells and inhibition of enteropathogen-cell interactions. Appl Environ Microbiol. 1993;59(12):4121-8.
17. Morita H, He F, Fuse T, Ouwehand AC, Hashimoto H, Hosoda M, Mizumachi K, Kurisaki Ji. Adhesion of Lactic Acid Bacteria to Caco-2 Cells and Their Effect on Cytokine Secretion. Microbiol Immunol. 2002;46(4):293-7.
18. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat Rev Immunol. 2008;8(6):411-20.
19. Kamada N, Seo S-U, Chen GY, Nunez G. Role of the gut microbiota in immunity and inflammatory disease. Nat Rev Immunol. 2013;13(5):321-35.
20. Littman DR, Rudensky AY. Th17 and regulatory T cells in mediating and restraining inflammation. Cell. 2010;140(6):845-58.
21. Erdman SE, Poutahidis T. Probiotic 'glow of health': it's more than skin deep. Benefic Microbes. 2014;5(2):109-19.
22. Bravo JA, Forsythe P, Chew MV, Escaravage E, Savignac HM, Dinan TG, Bienenstock J, Cryan JF. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci. 2011;108(38):16050-5.
23. Thomas CM, Hong T, van Pijkeren JP, Hemarajata P, Trinh DV, Hu W, Britton RA, Kalkum M, Versalovic J Histamine derived from probiotic Lactobacillus reuteri suppresses TNF via modulation of PKA and ERK signaling. PLoS One. 2012;7(2):e31951.
24. Yan F, Cao H, Cover TL, Whitehead R, Washington MK, Polk DB. Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. Gastroenterology. 2007;132(2):562-75.
25. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D et al. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461(7268):1282-6.
26. Matsumoto M, Kurihara S, Kibe R, Ashida H, Benno Y. Longevity in mice is promoted by probiotic-induced suppression of colonic senescence dependent on upregulation of gut bacterial polyamine production. PLoS One. 2011;6(8):e23652.
27. Watanabe T, Nishio H, Tanigawa T, Yamagami H, Okazaki H, Watanabe K, Tominaga K, Fujiwara Y, Oshitani N, Asahara T et al. Probiotic Lactobacillus casei strain Shirota prevents indomethacin-induced small intestinal injury: involvement of lactic acid. Am J Physiol Gastroint Liver Physiol. 2009;297(3):G506-13.
28. Chanput W, Mes JJ, Wichers HJ. THP-1 cell line: an in vitro cell model for immune modulation approach. Int Immunopharmacol. 2014;23(1):37-45.
29. Menard S, Candalh C, Bambou JC, Terpend K, Cerf-Bensussan N, Heyman M. Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transport. Gut. 2004;53(6):821-8.
30. Imaoka A, Shima T, Kato K, Mizuno S, Uehara T, Matsumoto S, Setoyama H, Hara T, Umesaki Y. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol. 2008;14(16):2511-6.
31. Jensen H, Dromtorp SM, Axelsson L, Grimmer S. Immunomodulation of monocytes by probiotic and selected lactic Acid bacteria. Probiotics Antimicrob Proteins. 2015;7(1):14-23.
32. Šušković J, Kos B, Beganović J, Leboš Pavunc A, Habjanič K, Matošić S. Antimicrobial activity-the most important property of probiotic and starter lactic acid bacteria. Food Technol Biotechnol. 2010;48(3):296-307.
33. Shokryazdan P, Sieo CC, Kalavathy R, Liang JB, Alitheen NB, Faseleh Jahromi M, Ho YW. Probiotic Potential of Lactobacillus Strains with Antimicrobial Activity against Some Human Pathogenic Strains. BioMed Res Int. 2014;2014:16.
34. Ouwehand AC, Salminen S. In vitro adhesion assays for probiotics and their in vivo relevance: a review. Microb Ecol Health Dis. 2003;15(4):175-84.
35. Kang JH, Yun SI, Park MH, Park JH, Jeong SY, Park HO. Anti-obesity effect of Lactobacillus gasseri BNR17 in high-sucrose diet-induced obese mice. PLoS One. 2013;8(1):e54617.
36. Poutahidis T, Springer A, Levkovich T, Qi P, Varian BJ, Lakritz JR, Ibrahim YM, Chatzigiagkos A, Alm EJ, Erdman SE. Probiotic microbes sustain youthful serum testosterone levels and testicular size in aging mice. PLoS One. 2014;9(1):e84877.
37. Midzak AS, Chen H, Papadopoulos V, Zirkin BR. Leydig cell aging and the mechanisms of reduced testosterone synthesis. Mol Cell Endocrinol. 2009;299(1):23-31.
38. Levkovich T, Poutahidis T, Smillie C, Varian BJ, Ibrahim YM, Lakritz JR, Alm EJ, Erdman SE. Probiotic bacteria induce a 'glow of health'. PLoS One. 2013;8(1):e53867.
39. Hemarajata P, Gao C, Pflughoeft KJ, Thomas CM, Saulnier DM, Spinler JK, Versalovic J. Lactobacillus reuteri-specific immunoregulatory gene rsiR modulates histamine production and immunomodulation by Lactobacillus reuteri. J Bacteriol. 2013;195(24):5567-76.
40. Liu Y, Fatheree NY, Mangalat N, Rhoads JM. Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation. Am J Physiol Gastroint Liver Physiol. 2010;299(5):G1087-96.
41. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM et al. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 2013;8(7):e68596.
42. Liu Y, Tran DQ, Fatheree NY, Marc Rhoads J. Lactobacillus reuteri DSM 17938 differentially modulates effector memory T cells and Foxp3+ regulatory T cells in a mouse model of necrotizing enterocolitis. Am J Physiol Gastroint Liver Physiol. 2014;307(2):G177-86.
43. Dao Jr H, Kazin RA. Gender differences in skin: a review of the literature. Gender Med. 2007;4(4):308-28.
44. McCabe LR, Irwin R, Schaefer L, Britton RA. Probiotic Use Decreases Intestinal Inflammation and Increases Bone Density in Healthy Male but not Female Mice. J Cell Physiol. 2013;228(8):1793-8.
45. Karunasena E, McMahon KW, Chang D, Brashears MM. Host responses to the pathogen Mycobacterium avium subsp. paratuberculosis and beneficial microbes exhibit host sex specificity. Appl Environ Microbiol. 2014;80(15):4481-90.
46. Celiberto LS, Bedani R, Rossi EA, Cavallini DC. The Scientific Evidence in the Context of Inflammatory Bowel Disease. Crit Rev Food Sci Nutr. doi: 10.1080/10408398.2014.941457.
47. Bradley JR. TNF-mediated inflammatory disease. J Pathol. 2008;214(2):149-60.
48. Chun J, Lee JH, Jung Y, Kim M, Kim S, Kim BK, Lim YW. EzTaxon: a web-based tool for the identification of prokaryotes based on 16S ribosomal RNA gene sequences. Int J Syst Evol Microbiol. 2007;57(Pt 10):2259-61.
49. Müller-Röver S, Handjiski B, van der Veen C, Eichmuller S, Foitzik K, McKay IA, Stenn KS, Paus R. A comprehensive guide for the accurate classification of murine hair follicles in distinct hair cycle stages. J Invest Dermatol. 2001;117(1):3-15.